Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
Ivermectin
Norbrook Laboratories Limited
QP54AA01
Ivermectin
1.0 percent weight/volume
Solution for injection
LM: Licensed Merchant as defined in relevant national legislation
Sheep
ivermectin
Endectoparasiticides
Authorised
2001-06-29
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Noromectin 1.0% w/v Solution for Injection for Sheep. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Each ml: Ivermectin 10.0 mg For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. A clear, colourless to pale yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Indicated for the treatment of infections by the following species of gastrointestinal roundworms, lungworms, nasal bots and psoroptic mange (sheep scab). GASTROINTESTINAL ROUNDWORMS (ADULTS AND FOURTH STAGE LARVAE): _Ostertagia circumcincta_ (including inhibited larvae_), Haemonchus contortus_ (including inhibited larvae),_ Trichostrongylus_ _axei_ (adults_),_ _Trichostrongylus colubriformis_ (adults)_,_ _Trichostrongylus vitrinus_ (adults_),_ _Cooperia curticei,_ _Nematodirus_ _filicollis_. LUNGWORMS: _Dictyocaulus filaria_ (adults and fourth stage larvae) NASAL BOTS: _Oestrus ovis_ (all larval stages) MANGE MITES: _Psoroptes ovis_ 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to ivermectin. Do not administer by the intravenous or intramuscular route. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _9_ _/_ _0_ _8_ _/_ _2_ _0_ _1_ _5_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _1_ _3_ _7_ _9_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Treatment of psoroptic ma Прочитайте повний документ